CURRENT UNDERSTANDING ON PATHOGENESIS AND EFFECTIVE TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE IB WITH EMPAGLIFLOZIN: NEW INSIGHTS COMING FROM DIABETES FOR ITS POTENTIAL IMPLICATIONS IN OTHER METABOLIC DISORDERS

Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders

Glycogen storage type Ib (GSDIb) is a rare inborn error of metabolism caused by glucose-6-phosphate transporter (G6PT, SLC37A4) deficiency.G6PT defect results in excessive accumulation of glycogen and fat in the liver, kidney, and intestinal mucosa and into both glycogenolysis and gluconeogenesis impairment.Clinical features include hepatomegaly, h

read more


Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2

Abstract Background MicroRNAs (miRNAs) are implicated in the progression of ischemic stroke (IS) jolly rancher filled gummies and bone marrow-derived mesenchymal stem cells (BMSCs)-derived exosomes play a role in IS therapy.Herein we hypothesized that the BMSCs-derived exosomes containing overexpressed miR-138-5p could protect the astrocytes follow

read more